Fidelity Investments’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237M | Buy |
5,431,994
+1,022,760
| +23% | +$44.6M | 0.01% | 755 |
|
|
2025
Q1 | $121M | Sell |
4,409,234
-421,189
| -9% | -$11.5M | 0.01% | 1015 |
|
|
2024
Q4 | $194M | Sell |
4,830,423
-278,718
| -5% | -$11.2M | 0.01% | 835 |
|
|
2024
Q3 | $242M | Buy |
5,109,141
+282,301
| +6% | +$13.4M | 0.01% | 761 |
|
|
2024
Q2 | $144M | Buy |
4,826,840
+462,430
| +11% | +$13.8M | 0.01% | 905 |
|
|
2024
Q1 | $175M | Buy |
4,364,410
+3,829,810
| +716% | +$154M | 0.01% | 841 |
|
|
2023
Q4 | $13.6M | Sell |
534,600
-335,947
| -39% | -$8.55M | ﹤0.01% | 1743 |
|
|
2023
Q3 | $12.1M | Buy |
870,547
+32,335
| +4% | +$449K | ﹤0.01% | 1770 |
|
|
2023
Q2 | $19.3M | Buy |
838,212
+170,861
| +26% | +$3.93M | ﹤0.01% | 1654 |
|
|
2023
Q1 | $19.8M | Sell |
667,351
-178,695
| -21% | -$5.29M | ﹤0.01% | 1611 |
|
|
2022
Q4 | $21.1M | Buy |
846,046
+520,360
| +160% | +$13M | ﹤0.01% | 1593 |
|
|
2022
Q3 | $7.09M | Sell |
325,686
-21,098
| -6% | -$459K | ﹤0.01% | 2045 |
|
|
2022
Q2 | $6.83M | Sell |
346,784
-1,577,105
| -82% | -$31.1M | ﹤0.01% | 2131 |
|
|
2022
Q1 | $81.4M | Sell |
1,923,889
-423,638
| -18% | -$17.9M | 0.01% | 1163 |
|
|
2021
Q4 | $149M | Sell |
2,347,527
-8,280
| -0.4% | -$526K | 0.01% | 913 |
|
|
2021
Q3 | $138M | Buy |
2,355,807
+173,378
| +8% | +$10.2M | 0.01% | 970 |
|
|
2021
Q2 | $106M | Sell |
2,182,429
-169,909
| -7% | -$8.24M | 0.01% | 1101 |
|
|
2021
Q1 | $91.4M | Sell |
2,352,338
-89,722
| -4% | -$3.49M | 0.01% | 1106 |
|
|
2020
Q4 | $151M | Buy |
2,442,060
+180,592
| +8% | +$11.2M | 0.01% | 863 |
|
|
2020
Q3 | $73.1M | Buy |
+2,261,468
| New | +$73.1M | 0.01% | 1056 |
|